NOVOEIGHT

Reason for request

Clinical Benefit

Substantial

The actual benefit of NOVOEIGHT is substantial.

Clinical Added Value

no clinical added value

NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments.